RNA targeting and cleavage by the type III-Dv CRISPR effector complex
Schwartz EA, Bravo JPK, Ahsan M, Macias LA, McCafferty CL, Dangerfield TL, Walker JN, Brodbelt JS, Palermo G, Fineran PC, Fagerlund RD, Taylor DW. 2024. RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature Communications. 15, 3324.
Download (ext.)
https://doi.org/10.1038/s41467-024-47506-y
[Published Version]
Journal Article
| Published
| English
Scopus indexed
Author
Schwartz, Evan A.;
Bravo, JackISTA ;
Ahsan, Mohd;
Macias, Luis A.;
McCafferty, Caitlyn L.;
Dangerfield, Tyler L.;
Walker, Jada N.;
Brodbelt, Jennifer S.;
Palermo, Giulia;
Fineran, Peter C.;
Fagerlund, Robert D.;
Taylor, David W.
All
All
Abstract
CRISPR-Cas are adaptive immune systems in bacteria and archaea that utilize CRISPR RNA-guided surveillance complexes to target complementary RNA or DNA for destruction<jats:sup>1–5</jats:sup>. Target RNA cleavage at regular intervals is characteristic of type III effector complexes<jats:sup>6–8</jats:sup>. Here, we determine the structures of the <jats:italic>Synechocystis</jats:italic> type III-Dv complex, an apparent evolutionary intermediate from multi-protein to single-protein type III effectors<jats:sup>9,10</jats:sup>, in pre- and post-cleavage states. The structures show how multi-subunit fusion proteins in the effector are tethered together in an unusual arrangement to assemble into an active and programmable RNA endonuclease and how the effector utilizes a distinct mechanism for target RNA seeding from other type III effectors. Using structural, biochemical, and quantum/classical molecular dynamics simulation, we study the structure and dynamics of the three catalytic sites, where a 2′-OH of the ribose on the target RNA acts as a nucleophile for in line self-cleavage of the upstream scissile phosphate. Strikingly, the arrangement at the catalytic residues of most type III complexes resembles the active site of ribozymes, including the hammerhead, pistol, and Varkud satellite ribozymes. Our work provides detailed molecular insight into the mechanisms of RNA targeting and cleavage by an important intermediate in the evolution of type III effector complexes.
Publishing Year
Date Published
2024-04-18
Journal Title
Nature Communications
Publisher
Springer Nature
Volume
15
Article Number
3324
ISSN
IST-REx-ID
Cite this
Schwartz EA, Bravo JPK, Ahsan M, et al. RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature Communications. 2024;15. doi:10.1038/s41467-024-47506-y
Schwartz, E. A., Bravo, J. P. K., Ahsan, M., Macias, L. A., McCafferty, C. L., Dangerfield, T. L., … Taylor, D. W. (2024). RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature Communications. Springer Nature. https://doi.org/10.1038/s41467-024-47506-y
Schwartz, Evan A., Jack Peter Kelly Bravo, Mohd Ahsan, Luis A. Macias, Caitlyn L. McCafferty, Tyler L. Dangerfield, Jada N. Walker, et al. “RNA Targeting and Cleavage by the Type III-Dv CRISPR Effector Complex.” Nature Communications. Springer Nature, 2024. https://doi.org/10.1038/s41467-024-47506-y.
E. A. Schwartz et al., “RNA targeting and cleavage by the type III-Dv CRISPR effector complex,” Nature Communications, vol. 15. Springer Nature, 2024.
Schwartz EA, Bravo JPK, Ahsan M, Macias LA, McCafferty CL, Dangerfield TL, Walker JN, Brodbelt JS, Palermo G, Fineran PC, Fagerlund RD, Taylor DW. 2024. RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature Communications. 15, 3324.
Schwartz, Evan A., et al. “RNA Targeting and Cleavage by the Type III-Dv CRISPR Effector Complex.” Nature Communications, vol. 15, 3324, Springer Nature, 2024, doi:10.1038/s41467-024-47506-y.
All files available under the following license(s):
Copyright Statement:
This Item is protected by copyright and/or related rights. [...]
Link(s) to Main File(s)
Access Level
Open Access
Export
Marked PublicationsOpen Data ISTA Research Explorer
Sources
PMID: 38637512
PubMed | Europe PMC